RxDoctor Payments Data

Patrick Aufiero

Infectious Disease · Hamilton, NJNPI 1649295270

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 370 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,482 and has fallen 95.5% since, to $66 in 2023.

$4,572in general payments, 2019–2025

Across 370 payments — averaging $12.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$1K
  • AbbVie$797
  • Gilead$703
  • Merck$490
  • Johnson & Johnson$433
  • Paratek Pharmaceuticals, Inc.$381
  • plus $705 from 14 others

What the payments were for

  • Food & beverage$4,42497%
  • Education$1483%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,572 in reported general payments places this provider in the 80th percentile of 334 infectious disease providers in New Jersey.

See all infectious disease providers in New Jersey →

Other infectious disease in Hamilton

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →